INFORMATION BY CANCER TYPE

Myelodysplastic syndrome

Clinical Trials Are Crucial to Advance MPN Treatment
BY Gina Columbus
Clinical trial enrollment is vital for the field of MPN treatment to continue to progress forward. 
Can a Cancer Diagnosis Cause PTSD?
BY Jane Biehl PhD
The diagnosis of a life-changing event can cause trauma. Here are some guidelines to help.
Costs of MPN Clinical Trials May Hinder Enrollment
BY Brielle Urciuoli
While clinical trials are paving the way for new treatments to treat hematologic malignancies, but many patients are apprehensive to participate in them after considering the costs.
Worry or Embrace With Cancer: It's My Choice
BY Jane Biehl PhD
What do we do when we get a bad report from the oncologist? How do we cope? Here is one suggestion.
Investigating Diet and Nutrition's Effects on MPNs
BY Brielle Urciuoli
An ongoing trial is seeking to find out if a patient with an MPN can improve their health status through nutritional interventions. 
NCCN May Already Be Updating MPN Guidelines
BY Lisa Miller
After publishing them in October 2016,the National Comprehensive Cancer Network (NCCN) is already seeking to update and expand their guidelines for diagnosing and treating patients with myeloproliferative neoplasms (MPNs).
Weill Cornell Expert,
BY Gina Columbus
Finola Hughes from TV's "General Hospital" and Ellen K. Ritchie, M.D. are teaming up to raise awareness for polycythemia vera.
Being Vulnerable With Cancer Is OK
BY Jane Biehl, Ph.D.
Andrew Schorr on How Journalism Led Him to Patient Advocacy
BY Andrew Schorr
Andrew Schorr, founder of Patient Power and Patient Empowerment and 2016 MPN Hero, discusses how his background in journalism led him to patient advocacy.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Myelodysplastic-syndrome CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Myelodysplastic Syndromes Treatment (PDQ®)
Expert-reviewed information summary about the treatment of myelodysplastic syndromes.
Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)
Expert-reviewed information summary about the treatment of myelodysplastic/myeloproliferative neoplasms including chronic/juvenile myelomonocytic leukemias and atypical CML.
Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)
Expert-reviewed information summary about the treatment of myelodysplastic/myeloproliferative neoplasms including chronic/juvenile myelomonocytic leukemias and atypical CML.
x